BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Pharmasset, Inc. 

303-A College Road East

Princeton  New Jersey  08540  U.S.A.
Phone: 609-613-4100 Fax: 609-613-4150


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Gilead Sciences, Inc. (GILD) Bets on Hepatitis C Data to Justify Pharmasset, Inc. (VRUS)'s $10.8 Billion Deal 4/12/2012 8:05:18 AM
Gilead Sciences Ltd. (GILD) Completes Acquisition of Pharmasset, Inc. (VRUS) 1/18/2012 5:58:07 AM
Gilead Sciences, Inc. (GILD) Completes Tender Offer for All Outstanding Shares of Pharmasset, Inc. (VRUS) 1/12/2012 6:28:32 AM
Pharmasset, Inc. (VRUS) to Change Design of Hepatitis C Treatment Study, Says Trial Change Won't Affect Gilead Sciences, Inc. (GILD) Takeover 12/16/2011 8:11:27 AM
Gilead Sciences, Inc. (GILD) to Acquire Pharmasset, Inc. (VRUS) for $11 Billion 11/21/2011 7:16:28 AM
Pharmasset, Inc. (VRUS) Reports Fiscal Year End 2011 Financial Results 11/15/2011 6:11:51 AM
Pharmasset, Inc. (VRUS) to Present at the Lazard Capital Markets Healthcare Conference 11/14/2011 12:24:59 PM
Pharmasset, Inc. (VRUS) Rises After Hepatitis-C Drug Shows 100% Cure Rate in Trial 11/7/2011 8:35:53 AM
Pharmasset, Inc. (VRUS) to Webcast an Investor Event from the AASLD Meeting 11/4/2011 11:50:17 AM
Pharmasset, Inc. (VRUS) Release: New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination Study of PSI-7977 and Daclatasvir (BMS-790052) for HCV Genotype 1 11/4/2011 11:15:32 AM
12345678910...